AHCA, Obamacare Repeal, and the In Vitro Diagnostics (IVD) Industry

AHCA, Obamacare Repeal, and the In Vitro Diagnostics (IVD) Industry

Diagnostics companies seek to resolve four main policy issues, according to industry interviews and public statements


Uncertain Consequences for U.S. Health Care Post-Election

Uncertain Consequences for U.S. Health Care Post-Election

Incoming Republican congressional majorities and an administration of president-elect Trump have injected plenty of uncertainty into the U.S. healthcare system. Dismantling the Affordable Care Act (ACA) will be a legislative priority of the new regime, but could take years to accomplish. Which ACA provisions are kept and how coverage is preserved for newly insured individuals are currently open questions.

  • by bcarlson@marketresearch.com
  • September 30 2014
  • ACA
  • IVD


PPACA One year Anniversary and the IVD Segment

PPACA One year Anniversary and the IVD Segment

Today marks the one year anniversary of when the Patient Protection and Affordable Care Act (PPACA) Health Insurance Exchange Marketplaces opened. Kalorama has analyzed the impact of the ACA on the in vitro diagnostics industry in the past. Let’s take a look at where things stand with respect to the Act and the IVD segment.

Improving economic conditions, the PPACA coverage expansions, and the aging of the population should drive faster projected growth in health spending in 2014 and beyond. Th...